Posts tagged with ‘marine ingredient’

  • Algae genome could aid medical, climate research

    A ubiquitous phytoplankton found in oceans around the world could hold the key to fields ranging from climatology to dentistry, since a team of scientists led by Cal State San Marcos researchers unlocked the genomes for 14 different strains of the algae. Their findings, published last week in the journal Nature, decoded the DNA of related strains of the algae […]
    0
  • Biotec Pharmacon subsidiary awarded NOK 5 million research grant

    ArcticZymes AS, a subsidiary company of Biotec Pharmacon ASA, has received a grant of NOK 5 million from the The Research Council of Norway, for a project titled “Functionalization of enzymes from marine bioprospecting”. The total project budget is NOK approx. 10 million over 3 years. The project is a user driven innovation project which aims to accelerate the commercialization […]
    0
  • Mar. Drugs, Volume 10, Issue 8 (August 2012), Pages 1619-1898 Newly Released

    MDPI is pleased to announce the publication of the following issue: Mar. Drugs, Volume 10, Issue 8 (August 2012), Pages Pages 1619-1898 TOC: Anthony D. Wright, Jonathan L. Nielson, Dianne M. Tapiolas, Catherine H. Liptrot and Cherie A. Motti Article: A Great Barrier Reef Sinularia sp. Yields Two New Cytotoxic Diterpenes Mar. Drugs 2012, 10(8), 1619-1630; doi:10.3390/md10081619 http://www.mdpi.com/1660-3397/10/8/1619/ Vânia Cristina Desoti, […]
    0
  • Chitosan used to lengthen shelf life of bananas in China

    Scientists have figured out how to use chitosan — a substance derived from shrimp and crab shells — to delay the ripening of bananas for up to two weeks. Scientists speaking in Philadelphia at the 244th National Meeting & Exposition of the American Chemical Society described experiments designed to develop a spray-on coating that consumers could use themselves. The coating, […]
    0
  • Sapphire Energy’s Commercial Demonstration Algae-To-Energy Facility Now Operational

    Sapphire Energy, Inc., one of the world leaders in algae-based green crude oil production, today announced the first phase of its Green Crude Farm, the world’s first commercial demonstration algae-to-energy facility, is now operational. Construction of this first phase, which began on June 1, 2011, was completed on time and on budget. When completed, the facility will produce 1.5 million […]
    0
  • Shrividya Enterprises announces addition to capacity of Chitin and Protein

    Shrividya Enterprises, Mumbai, India based manufacturer of Chitin and Protein announced increase in the production capacity: Chitin capacity is increased from 40MT Per year to 60MT per year and Protein capacity increased from 108MT per year to 216MT per year Chitin is basic raw material for upstream compounds such as ,Glucosamine Sulphate and Chitosan.Chitin Is Extracted from shrimp/ Prawn shells. Chitin […]
    0
  • Toxins from algae prove in demand

    Nelson’s Cawthron Institute has broken into an international market selling minute quantities of organic compounds sourced from algae and worth 50,000 times the price of gold. A level teaspoon of the compounds was worth several million dollars, acting chief executive Daryl Wehner said today. “Our sales over the first nine months have exceeded a quarter of a million dollars and […]
    0
  • Aqua Bio Technology Signs Milestone Sales Agreement for Marine-Derived Ingredient

    Aqua Bio Technology ASA (Oslo Axess: ABT) today announced a partnership with Amway, one of the world’s largest direct sellers, for the use of ABT’s lead marine-derived ingredient Aquabeautine XL® in ARTISTRY® skincare products. ABT expects the agreement to provide revenues of at least NOK 8 million over the next 30 months, with a significant upside potential. “The agreement with […]
    0
  • Marine biotech in Norway continues to make waves

    Some 30 million NOK are to be made available for new initiatives alongside continuing support for established programmes such as MABIT and Marbank. The Norwegian government acknowledged awareness of the importance of marine biotech to the economy by allocating dedicated funds within the new budget in October. Some 30 million NOK (3,84 million EUR) are to be made available for new […]
    0
  • Marinova reports two clinical studies in pipeline

    Marinova has some exciting news to report in the area of new clinical trials. Reflecting a commitment to developing novel fucoidan compounds with proven therapeutic efficacy, they have just commenced two new clinical trials. These two studies will investigate the potential of Maritech® fucoidan in the following clinical settings: • Osteoarthritis and Inflammation This is a large multi-site trial, directly […]
    0